In contrast to the findings of Huang et al. showing that knocking down CLDN3 reduced ovarian tumor growth, Shang et al. demonstrated that knocking down Cldn3 and Cldn4 expression in an ovarian cancer xenograft model led to an increase in tumor growth and metastatic potential [18, 27]. The gene discussed is CLDN4; the disease is ovarian cancer.